Subscribe to our Email Alerts

Island Pharmaceuticals
  • About Us
    • Island at a glance
    • Board
    • Key Management
    • Scientific Advisory Board
    • Collaborations
  • Science
    • About ISLA-101
    • Scientific Publications
    • Drug repurposing and benefits
    • Disease and drug terms explained
  • Investor Centre
    • Investor Welcome
      • Clinical programme
    • ASX Announcements
    • Presentations
    • Prospectus
    • Financial Reports
    • Share Price Information
    • Shareholder Services
    • Investor Fact Sheet
    • Corporate Governance
    • Corporate Directory
    • International Investors
    • Research Coverage
    • AGM
  • Media
    • News
    • IslandWatch Newsletter
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Media
Media > News
  • News
  • IslandWatch Newsletter

News

Filter by Year:2025 2024 2023 2022 2021 2020 
16-May-2023
Island Pharmaceuticals receives FDA green light for dengue virus ISLA-101 clinical program
17-Apr-2023
Island Pharmaceuticals completes major body of work as it responds to FDA's ISLA-101 requests
9-Feb-2023
Connecting the world to powerful outcomes: Island Pharmaceuticals
9-Feb-2023
Connecting the world to powerful outcomes: David Foster
1-Feb-2023
Island Pharmaceuticals "appreciates" detailed FDA feedback on IND application
23-Jan-2023
Island CEO Dr David Foster discusses FDA feedback on IND for ISLA-101 clinical study
20-Jan-2023
Island Pharmaceuticals receives FDA feedback on IND for Phase 2a clinical trial of dengue vaccine
16-Jan-2023
Island Pharmaceuticals could see a re-rating on positive Phase 2a results in H2CY23: MST Access
5-Jan-2023
Island Pharmaceuticals on track to begin ISLA-101 Phase 2a clinical trial in early 2023: MST Access Research
  • Previous 
  • 1
  • 2
  • 3

NOTICE

It has come to the company's attention that unauthorised individuals may be falsely claiming to represent Island Pharmaceuticals Limited in employment offers and recruitment communications. Please be advised that all legitimate employment opportunities are advertised through official company channels, the company's social media channels and via authorised recruitment partners.

Island Pharmaceuticals Limited will never request payment, personal financial information, or conduct interviews via unofficial platforms. If you receive a suspicious message or offer, please report it to us immediately at henry.jordan@sdir.com.au

Your safety and security are important to us.

Kind regards,
Island Pharmaceuticals Limited

Quick Links

Contact Us

Island Pharmaceuticals
Suite 201, 697 Burke Road
Camberwell, Victoria 3124

info@islandpharmaceuticals.com

www.islandpharmaceuticals.com

Email Alerts

Which of the following group do you best fit?

 

Follow Us

Follow Us

Site Map Privacy Search
Copyright © Island Pharmaceuticals
Site Map Privacy Search
Site by